Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation

Authors: Haas, Martin, Leko-Mohr, Zdenka, Roschger, Paul, Kletzmayr, Josef, Schwarz, Christoph, Mitterbauer, Christa, Steininger, Rudolf, Grampp, Stefan, Klaushofer, Klaus, Delling, Günter, Oberbauer, Rainer ^*

Source: In Kidney International March 2003 63(3):1130-1136

Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy

Authors: Haas, Martin, Leko-Mohr, Zdenka, Erler, Christoph, Mayer, Gert

Source: In American Journal of Kidney Diseases September 2002 40(3):458-463

Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients

Authors: Haas, Martin, Leko-Mohr, Zdenka, Roschger, Paul, Kletzmayr, Josef, Schwarz, Christoph, Domenig, Christoph, Zsontsich, Thomas, Klaushofer, Klaus, Delling, Günter, Oberbauer, Rainer

Source: In American Journal of Kidney Diseases March 2002 39(3):580-586

Peri‐operative immunoadsorption in sensitized renal transplant recipients.

Authors: Haas, Martin, Böhmig, Georg A., Leko‐Mohr, Zdenka, Exner, Markus, Regele, Heinz, Derfler, Kurt, Hörl, Walter H., Druml, Wilfred

Source: Nephrology Dialysis Transplantation; Aug2002, Vol. 17 Issue 8, p1503-1508, 6p